SCHEMBL30253404

SCHEMBL30253404

Cc1ccc(CCn2nc3c(cc(O)c4ccccc43)c2C)cc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GRN P28799 1/20 0.36
▸ SORT1 Q99523 1/20 0.36
▸ IGF1R P08069 1/20 0.36
▸ ALOX15 P16050 1/20 0.36
▸ CASP3 P42574 2/20 0.35
▸ CASP7 P55210 2/20 0.35
▸ GFER P55789 1/20 0.35
▸ HDAC3 O15379 2/20 0.34
▸ HDAC4 P56524 2/20 0.34
▸ HDAC1 Q13547 2/20 0.34
▸ HDAC7 Q8WUI4 2/20 0.34
▸ HDAC2 Q92769 2/20 0.34
▸ HDAC10 Q969S8 2/20 0.34
▸ HDAC11 Q96DB2 2/20 0.34
▸ HDAC8 Q9BY41 2/20 0.34
▸ HDAC6 Q9UBN7 2/20 0.34
▸ HDAC9 Q9UKV0 2/20 0.34
▸ HDAC5 Q9UQL6 2/20 0.34
▸ NCOR2 Q9Y618 2/20 0.34
▸ HRH3 Q9Y5N1 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25263468 1.00 GRN (0.36) GRNSORT1IGF1RALOX15CASP3
SCHEMBL25303432 0.90 MAPT (0.41) GFERKMT2ASMN1; SMN2CASRHTT
SCHEMBL30253661 0.90 MAPT (0.41) GFERKMT2ASMN1; SMN2CASRHTT
SCHEMBL30253485 0.82 MEN1 (0.39) MEN1LMNAKMT2ASMN1; SMN2
SCHEMBL25302089 0.82 MEN1 (0.39) MEN1LMNAKMT2ASMN1; SMN2
SCHEMBL25299954 0.80 KDM4E (0.44) CASP3CASP7MEN1KMT2ACASR
SCHEMBL29405132 0.80 KDM4E (0.44) CASP3CASP7MEN1KMT2ACASR
SCHEMBL25255812 0.80 GFER (0.38) GRNSORT1IGF1RALOX15CASP3
SCHEMBL29404923 0.80 GFER (0.38) GRNSORT1IGF1RALOX15CASP3
SCHEMBL25302796 0.74 HTT (0.43) CASP7MEN1LMNAKMT2AMYC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115956071-A Imidazoquinoline or benzindazolone compounds and intermediates for their preparation LMITO药业株式会社 2023-04-11 — — CN disclosed
Send feedback